M. Verbruggen

v-Raf Murine Sarcoma Viral Oncogene Mutation Status in Serous Borderline Ovarian Tumors and the Effect on Clinical Behavior

P. V. van Diest, J. Dorsman, D. Rockx, 2009, International Journal of Gynecologic Cancer.

The Prognostic and Clinical Value of Morphometry and DNA Cytometry in Borderline Ovarian Tumors: A Prospective Study

P. V. van Diest, J. Baak, P. Kenemans, 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

A case of loss of heterozygosity in the BRCA2 gene of a borderline ovarian tumor: case report and review of literature

P. V. van Diest, J. Dorsman, R. Verheijen, 2006, International Journal of Gynecologic Cancer.

Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?

F. Amant, D. van den Broek, V. van der Noort, 2022, Gynecologic oncology.

Molecular and clinical aspects of borderline ovarian tumours

M. Verbruggen, 2009 .

Psychological impact of referral to an oncology hospital on patients with an ovarian mass

F. Amant, J. Huirne, E. Bleiker, 2022, International Journal of Gynecological Cancer.

Serous Borderline Tumor of the Ovary Presenting With Cervical Lymph Node Involvement: A Report of 3 Cases

P. V. van Diest, J. Dorsman, R. Verheijen, 2006, The American journal of surgical pathology.

Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the ‘Dutch Gynecological Oncology Audit’

W. van Driel, K. Overmars, D. Boll, 2022, Gynecologic Oncology.